Abstract:Background: Managing healing of impaired bone fracture has long been a subject of concern. Prolonged or uncontrolled inflammation exerts detrimental effects on bone healing. Tμmor necrosis factor (TNF)-α is a critical inflammatory factor, whose absence impairs normal bone formation. However, TNF-α exposure for longer duration inhibits bone regeneration. In this study, we aim to find a new therapeutic target for the impaired osteogenesis induced by long exposure of TNF-α.Methods: In vitro, mRNA microarray analysis was used to identify differentially expressed genes. Cell proliferation assay was used to assess the proliferation of cells. qPCR and Western blotting analysis were applied to detect the expression of target genes and proteins respectively. ALP staining and Alizarin Red staining (ARS) were used to evaluate ALP activity and mineral deposition respectively. Co-immunoprecipitation was used to detect the interaction of proteins. In vitro , a murine tibial fracture model was established, histological evaluation and radiographic analysis was used to confirm bone regeneration in fracture healing. statistical significance between two groups was determined by Student’s t test, one-way ANOVA or Bonferroni’s post-hoc test according to the distribution of the tested population.Results: In this study, we show that heat shock protein family B (small) member 7 (HSPB7) mitigates negative impact of long-term TNF-α exposure on bone formation by binding heat shock protein family H (small) member 1 (HSPH1). HSPH1, in turn, inhibits the ATPase of heat shock cognate A8 (HSCA8), one of the key components involved in chaperone-mediated autophagy (CMA). Deletion of genes encoding for either HSCA8 or lysosome-associated membrane protein 2A (LAMP2A), another component of CMA, failed to reverse the osteogenic differentiation of hBMSCs induced by TNF-α by deleting HSPH1.Subsequently, transcriptome analysis was further used to explore downstream related pathways mediated by CMA. After LAMP2a gene knockdown, transcriptional analysis showed that the PI3K/AKT/GSK3β signaling pathway was significantly inhibited. LAMP2A overexpression reverse the impaired osteogenesis induced by TNF-α, and this effect was attenuated by DKK1, a specific Wnt/β-catenin signaling pathway inhibitors. Finally, we successfully constructed a mouse tibial fracture model and locally injected TNF-α to simulate the chronic inflammatory environment. Histological and imaging results showed that TNF-α significantly inhibited fracture healing, while the addition of HSPB7 overexpressed lentivirus successfully saved fracture healing. Thus, a heat shock protein family network composed by HAPB7, HSPH1 and HSCA8 rescued the impairment of bone healing by TNF-α through the CMA-mediated PI3K/AKT/GSK3β signaling pathway., making it a potential therapeutic agent for bone regeneration in cases of prolonged or severe inflammation in the clinical settings.Conclusions: Taken together, these findings indicate that a heat shock protein family network including HSPB7, HSPH1 and HSCA8 protects the impaired osteogenesis induced by TNF-α via CMA through PI3K/AKT/GSK3β/β-catenin pathway. And in vivo, HSPB7 overexpression lentiviral particles effectively protects the impaired fracture healing induced by TNF-α in a mouse tibia fracture healing model.Funding: This work was supported by grants from the National Natural Science Foundation of China (Nos. 81672147; Nos. 81874007).Declaration of Interest: The authors declare no conflicts of interest.Ethical Approval: All animal experiments were in accordance to the Animal Care and Use Committee guidelines of Zhejiang University. All experimental procedures were in accordance with the and Institutional Animal Care Use Committee at Zhejiang University.

mPPTMP195 nanoparticles enhance fracture recovery through HDAC4 nuclear translocation inhibition

Adipose-derived mesenchymal stem cells combined with platinum nanoparticles accelerate fracture healing in a rat tibial fracture model

Gold nanorods modified by endogenous protein with light-irradiation enhance bone repair via multiple osteogenic signal pathways

HSPB7 Protects Bone Formation from TNF-α Via Chaperone Mediated Autophagy Through PI3K/AKT/GSK3β/Β-Catenin Pathway

Bone-Targeted Nanoparticle Drug Delivery System-Mediated Macrophage Modulation for Enhanced Fracture Healing

Multifunctional BPs/MT@PLGA‐ALE Nanospheres for Treatment of Osteoporotic Fracture with Near‐Infrared Irradiation

Icaritin-Incorporated Porous Hollow Iron Oxide Nanostructures for Promoting Fracture Repair

The Sequential and Systemic Administration of BMP-2 and SDF-1α Nanocapsules for Promoting Osteoporotic Fracture Healing

Bisphosphonates Activated Keratin Assembled Nanoparticle Targeting Bone Fracture for Enhanced Immunomodulatory and Osteoinductivity

Accelerated fracture healing by osteogenic Ti45Nb implants through the PI3K–Akt signaling pathway

Mineral coated microparticles doped with fluoride and complexed with mRNA prolong transfection in fracture healing

Induction of Bone Remodeling by Raloxifene-Doped Iron Oxide Functionalized with Hydroxyapatite to Accelerate Fracture Healing

Systemic Administration of Enzyme-Responsive Growth Factor Nanocapsules for Promoting Bone Repair

Enhancement of Bone Tissue Regeneration with Multi-Functional Nanoparticles by Coordination of Immune, Osteogenic, and Angiogenic Responses

Treatment Promotion of Osteoporotic Fractures by microRNA-320 Nanocapsules Through Stimulating Bone Marrow Mesenchymal Stem Cells

Advancing Osteoporotic Bone Regeneration Through Tailored Tea Polyphenols Functionalized Micro‐/Nano‐ Hydroxyapatite Bioceramics

Macrophage membrane-reversibly camouflaged nanotherapeutics accelerate fracture healing by fostering MSCs recruitment and osteogenic differentiation

Magnetically-Targeted Nanoparticle-Guided M2 Macrophage Polarization For Fracture Healing Promotion

Regulation of Metabolic Microenvironment with a Nanocomposite Hydrogel for Improved Bone Fracture Healing

Dual-Targeted Nanoplatform Regulating the Bone Immune Microenvironment Enhances Fracture Healing

MiR-21 Nanocapsules Promote Early Bone Repair of Osteoporotic Fractures by Stimulating the Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells.